An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Protocol No
PULM-UNITED-TETON-OLE
Staff Member
Mark Barash
Phase
III
Summary

This project is being done to study long-term treatment of inhaled treprostinil in people with Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF).
Objective
Extension Study of Inhaled Treprostinil in Subjects With IPF
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Lungs and Breathing, ILD/IPF
ClinicalTrials.gov
https://www.clinicaltrials.gov/study/NCT04905693